Market Analysis - World Biotechnology 2017
The global biotechnology market size was valued at USD 270.5 billion in 2013 and is expected to grow at a CAGR of 12.3% owing to the increasing demand for diagnostics and therapeutics solutions such as recombinant technology, red biotechnology, and DNA sequencing. The increasing prevalence of diseases such as cancer, hepatitis B, and other orphan disorders is expected to serve as a high-impact rendering driver for this industry over the forecast period. Rising government initiatives owing to high significance towards growth of the economy are expected to boost the biotechnology market growth over the forecast period
Furthermore, the presence of organizations, such as the DBT, together with other government-funded institutions such as the NBTB and other autonomous organizations representing the biotechnology industry promotes funding to support R&D and product development exercises pertaining to the field and are expected to drive growth from 2013 to 2020.
Based on application, global biotechnology market is divided into biopharmaceutical, bio services, bio agriculture, and bio industrial. In 2013, biopharmaceuticals that are segmented into advanced drugs, orphan drugs, monoclonal antibodies, and recombinant proteins dominated the overall industry with around USD 184.21 billion revenue.
Recombinant proteins are expected to dominate the biopharmaceutical market over the forecast period owing to various vaccines manufactured with the help of bio recombinant proteins that are able to treat several diseases.
Bio services market is expected to have lucrative growth by 2020 due to rising clinical research initiatives by various pharmaceutical and biotechnological companies. The rising demand for cost cutting, stringent regulations, and increasing complexity of biotechnological processes are driving forces of this segment.
On the basis of geographical regions, global biotechnology market is segmented into North America, Europe, Latin America, Asia-Pacific, and MEA. North America accounted for the largest share of the overall industry in 2013, accounting for over 42.30% of the revenue share, as a result of increasing initiatives in R&D by various pharmaceutical companies.
Asia Pacific is expected to gain substantial market share and reach around USD 145.9 billion by 2020. Escalating awareness about the advantages associated with adoption and introduction of healthcare benefits by the government are driving forces for this region.
The global biotechnology market is consolidated in nature. The key players include Amgen, Novo Nordisk, Teva Pharmaceutical Industries, Regeneron, Roche Diagnostics, Alkermes, and Cubist Pharmaceuticals.
The market was dominated by Roche Diagnostics with a market share of 17.1% in 2013. Key strategies adopted by these companies to gain market share include strategic collaborations, mergers, outsourcing research & development, and manufacturing activities.
For instance, Sanofi-Aventis entered into collaboration with Transgene, Bristol-Myers Squibb, and Joslin Diabetes Center for the development of immunotherapy and diabetes products. To increase its presence in Latin America, the company acquired Genfar, a leading pharmaceutical company in Colombia. It has also acquired Pluromed to expand its presence in biosurgery.
The global white biotechnology market size was USD 203.28 billion in 2015 and is expected to witness growth at a CAGR of 10.2% over the forecast period on account of its increasing use in the manufacturing of biofuels such as bioethanol and biodiesel. About 4% of the chemical products including organic acids, amino acids, ethanol and numerous vitamins are manufactured using this technology.
Increasing technology use across various industries on account of its various advantages such as environment friendliness, new raw material chains, efficient production methods, reduced manufacturing costs, low waste generation and raw material consumption is expected to have a positive impact on the market over the next eight years.
Biotechnology in Brazil
The biotechnology market in Brazil has seen enormous activity this year in both the areas of industrial biotechnology and healthcare. In a recent webinar that discussed the latest results of the annual Scientific American Worldview report, panelists were especially excited by the partnering opportunities in Brazil. Mike May, Editorial Director, Scientific American Worldview, commented, “Brazil is, as a country, like a master of partnering. They partner in the country between industry and government. They partner outside the country with industry and industry in other places. They have huge networks of partnering. They’re bringing industries in from other countries to help them with things where maybe they don’t have the technology… So you know, it’s like they’re finding creative ways to deal with some of the challenges they have that, say, the United States doesn’t have.”
Building on this movement, BIO and Biominas have partnered to co-host the first annual bio Latin America September 9-11, 2014 in Rio de Janeiro, Brazil, the industry’s must-attend conference for innovation and collaboration in Latin America’s rapidly-growing biotechnology sector. Here is a look at the current state of the biotech market in Brazil.
The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.
This report provides:
· An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters.
· Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
· In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges.
· Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs.
· Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares.
· Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns.
· Relevant patent analysis.
For more deatils please visit :http://world.biotechnologycongress.com/conference-brochure.php
Conferenceseries welcomes you to attend the 2nd World Biotechnology Congress, during December 04-06, 2017 at Sao Paulo, Brazil. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Biotechnology and its applications with the theme “Meeting the Needs of a Changing World.”
This biotech meeting creates a platform for Policy-makers, Scientists, representatives and decision makers in biotechnology to present their latest biotech research and learn about all the important developments in biotechnology research. The applications of biotechnology include therapeutics, diagnostics, genetically modified crops for agriculture, processed food, bioremediation, waste treatment, and energy production. World Biotechnology-2017 is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. Major topics discussed are Molecular Biotechnology, Industrial and Pharmaceutical Biotechnology, Medical Biotechnology and Biomedical Engineering, Food Biotechnology, Tissue science and Genetic Engineering, Agriculture Biotechnology, Animal Biotechnology, Environmental Biotechnology, Nanobiotechnology, Bioinformatics and Biosensors, Biotechnology investments and Biotechnology Grants, latest biotech research.